References
- Tomkins-NetzerOIsmetovaFBarASeguin-GreensteinSKramerMLightmanSFunctional outcome of macular edema in different retinal disordersProg Retin Eye Res20154811913626014685
- CoscasGCunha-VazJSoubraneGMacular edema: definition and basic conceptsDev Ophthalmol20175811028351040
- InoueMKobayakawaSSotozonoCEvaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factorOphthalmologica2011226314515021811052
- DossarpsDBronAMKoehrerPAho-GléléLSCreuzot-GarcherCFRCR net (FRenCh Retina specialists net)Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcomeAm J Ophthalmol20151601172525892127
- SchlenkerMBThiruchelvamDRedelmeierDAIntravitreal anti-vascular endothelial growth factor treatment and the risk of thromboembolismAm J Ophthalmol20151603569580.e526116264
- TolentinoMSystemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular diseaseSurv Ophthalmol20115629511321335144
- PelléGShwekeNDuong Van HuyenJPSystemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitorsAm J Kidney Dis201157575675921295897
- GeorgalasIPapaconstantinouDPapadopoulosKPagoulatosDKaragiannisDKoutsandreaCRenal injury following intravitreal anti-VEGF administration in diabetic patients with proliferative diabetic retinopathy and chronic kidney disease a possible side effect?Curr Drug Saf20149215615824517109
- BranchiniLRegatieriCAdhiMEffect of intravitreous anti-vascular endothelial growth factor therapy on choroidal thickness in neovascular age-related macular degeneration using spectral-domain optical coherence tomographyJAMA Ophthalmol2013131569369423494008
- van der ReisMILa HeijECDe Jong-HesseYRingensPJHendrikseFSchoutenJSA systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injectionsRetina201331814491469
- FalavarjaniKGNguyenQDAdverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literatureEye (Lond)201327778779423722722
- KuriharaTWestenskowPDBravoSAguilarEFriedlanderMTargeted deletion of Vegfa in adult mice induces vision lossJ Clin Invest2012122114213421723093773
- KwongTQMohamedMAnti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the futureBr J Clin Pharmacol201478469970624602183
- NiegoBMedcalfRLPlasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?J Cereb Blood Flow Metab20143481283129624896566
- GingrichMBTraynelisSFSerine proteases and brain damage – is there a link?Trends Neurosci200023939940710941185
- MoneaSLehtiKKeski-OjaJMignattiPPlasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanismJ Cell Physiol2002192216017012115722
- JinRYangGLiGMolecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activatorNeurobiol Dis201038337638520302940
- RabbaniLEJohnstoneMTRuddMADevinePGeorgeDLoscalzoJPPACK attenuates plasmin-induced changes in endothelial integrityThromb Res19937064254368362368
- LaurbergGPlasma kinin activation in tranexamic acid treated patients with hereditary angioneurotic edemaArch Dermatol Res19782622153156686826
- MoroiMAokiNInhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitorJ Biochem1977824969972144728
- KleniewskiJBlankenshipDTCardinADDonaldsonVMechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasminJ Lab Clin Med199212011291391535355
- YaoYTsirkaSETruncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruptionJ Cell Sci2011124Pt 91486149521486949
- MilesLAParmerRJPlasminogen receptors: the first quarter centurySemin Thromb Hemost201339432933723532575
- NagyZKolevKCsonkaEPékMMachovichRContraction of human brain endothelial cells induced by thrombogenic and fibrinolytic factors. An in vitro cell culture modelStroke19952622652707831700
- NagyZKolevKCsonkaEVastagMMachovichRPerturbation of the integrity of the blood-brain barrier by fibrinolytic enzymesBlood Coagul Fibrinolysis1998964714789818996
- DoeuvreLPlawinskiLGouxDVivienDAnglés-CanoEPlasmin on adherent cells: from microvesiculation to apoptosisBiochem J2010432236537320846121
- TsirkaSEBuggeTHDegenJLStricklandSNeuronal death in the central nervous system demonstrates a non-fibrin substrate for plasminProc Natl Acad Sci U S A19979418977997819275201
- JungeCESugawaraTMannaioniGThe contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemiaProc Natl Acad Sci U S A200310022130191302414559973
- CunninghamOCampionSPerryVHMicroglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammationGlia200957161802181419459212
- OkamotoSSatoSTakadaYOkamotoUAn active stereo-isomer (trans-form) of AMCHA and its antifibrinolytic (antiplasmic) action in vitro and in vivoKeio J Med19641317718514279228
- TengbornLBlombäckMBerntorpETranexamic acid–an old drug still going strong and making a revivalThromb Res2015135223124225559460
- McCormackPLTranexamic acid: a review of its use in the treatment of hyperfibrinolysisDrugs201272558561722397329
- CamarriEAmerighiABellofiorePThe clinical use of tranexamic acid in acute inflammation of the upper respiratory tractG Clin Med1979601210101019 Italian540672
- WintenbergerCBoccon-GibodILaunayDTranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patientsClin Exp Immunol20141781112117
- ShefferALAustenKFRosenFSTranexamic acid therapy in hereditary angioneurotic edemaN Engl J Med197228794524544558045
- KerKEdwardsPPerelPShakurHRobertsIEffect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysisBMJ2012344e305422611164
- RossJAl-Shahi SalmanRThe frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trialsCurr Drug Saf201271445422663958
- PandolfiMHolmbergLTuressonICoagulation and platelet adhesion-inducing factor in the endothelium of the retinal vesselsAm J Ophthalmol197580147501098470
- AshtonNVascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973Br J Ophthalmol19745843443664138036
- GreenWRChanCCHutchinsGMTerryJMCentral retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 casesTrans Am Ophthalmol Soc19817913714227342407
- SperdutoRDHillerRChewERisk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control studyOphthalmology199810557657719593373
- BerntorpEFollrudCLethagenSNo increased risk of venous thrombosis in women taking tranexamic acidThromb Haemost200186271471511522029
- YangBLiHWangDHeXZhangCYangPSystematic review and meta-analysis of perioperative intravenous tranexamic acid use in spinal surgeryPLoS One20138e5543623424632
- CRASH-2 collaboratorsRobertsIShakurHThe importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trialLancet201137797711096110121439633
- GodierARobertsIHuntBJTranexamic acid: less bleeding and less thrombosis?Crit Care201216313522748073
- ShimuraMYasudaKYasudaMNakazawaTVisual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edemaRetina201333474074723222391
- KangHMChungEJKimYMKohHJSpectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusionGraefes Arch Clin Exp Ophthalmol2013251250150822653439
- OhashiHOhHNishiwakiHNonakaATakagiHDelayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusionOphthalmology2004111112050205615522371
- Abri AghdamKReznicekLSoltan SanjariMPeripheral retinal non-perfusion and treatment response in branch retinal vein occlusionInt J Ophthalmol20169685886227366688